| Reference |
|---|
Kaku C, Starr T, Zhou P, Dugan H, Khalif xe9 P, Song G, et al. Evolution of antibody immunity following Omicron BA.1 breakthrough infection. Nat Commun. 2023;14:2751 pubmed publisher |
Beck C, Casey N, Persiconi I, Moharrami N, Sike A, Jin Y, et al. Development of a TGFβ-IL-2/15 Switch Receptor for Use in Adoptive Cell Therapy. Biomedicines. 2023;11: pubmed publisher |
Fernandez R, Mayoral J, Pierre Louis L, Yao Y, Xu Y, Mu S, et al. Improving NK cell function in multiple myeloma with NKTR-255, a novel polymer-conjugated human IL-15. Blood Adv. 2023;7:9-19 pubmed publisher |
Khuisangeam N, Jewmoung S, Thaiwong R, Tudsamran S, Hirankarn N, Suppipat K, et al. An In Vitro Comparison of Costimulatory Domains in Chimeric Antigen Receptor T Cell for Breast Cancer Treatment. J Immunol Res. 2022;2022:2449373 pubmed publisher |
Barnes C, Schoofs T, Gnanapragasam P, Golijanin J, Huey Tubman K, Gruell H, et al. A naturally arising broad and potent CD4-binding site antibody with low somatic mutation. Sci Adv. 2022;8:eabp8155 pubmed publisher |
Aschmoneit N, Kocher K, Siegemund M, Lutz M, Kühl L, Seifert O, et al. Fc-based Duokines: dual-acting costimulatory molecules comprising TNFSF ligands in the single-chain format fused to a heterodimerizing Fc (scDk-Fc). Oncoimmunology. 2022;11:2028961 pubmed publisher |
Hakki S, Robinson E, Robson M. Circulating Interleukin-6 and CD16 positive monocytes increase following angioplasty of an arteriovenous fistula. Sci Rep. 2022;12:1427 pubmed publisher |
Mudd P, Minervina A, Pogorelyy M, Turner J, Kim W, Kalaidina E, et al. SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans. Cell. 2022;185:603-613.e15 pubmed publisher |
Kasper M, Heming M, Schafflick D, Li X, Lautwein T, Meyer Zu Hörste M, et al. Intraocular dendritic cells characterize HLA-B27-associated acute anterior uveitis. elife. 2021;10: pubmed publisher |
Aschmoneit N, K xfc hl L, Seifert O, Kontermann R. Fc-comprising scDb-based trivalent, bispecific T-cell engagers for selective killing of HER3-expressing cancer cells independent of cytokine release. J Immunother Cancer. 2021;9: pubmed publisher |
Bulgarelli J, Piccinini C, Petracci E, Pancisi E, Granato A, De Rosa F, et al. Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma. Front Immunol. 2021;12:778459 pubmed publisher |
Billing F, Walter B, Fink S, Arefaine E, Pickarski L, Maier S, et al. Altered Proinflammatory Responses to Polyelectrolyte Multilayer Coatings Are Associated with Differences in Protein Adsorption and Wettability. ACS Appl Mater Interfaces. 2021;13:55534-55549 pubmed publisher |
Wu X, Sharma A, Oldenburg J, Weiher H, Essler M, Skowasch D, et al. NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation. Front Immunol. 2021;12:731767 pubmed publisher |
Eiva M, Omran D, Chacon J, Powell D. Systematic analysis of CD39, CD103, CD137, and PD-1 as biomarkers for naturally occurring tumor antigen-specific TILs. Eur J Immunol. 2022;52:96-108 pubmed publisher |
Wu J, Chen Z, Wickström S, Gao J, He X, Jing X, et al. Interleukin-33 is a Novel Immunosuppressor that Protects Cancer Cells from TIL Killing by a Macrophage-Mediated Shedding Mechanism. Adv Sci (Weinh). 2021;8:e2101029 pubmed publisher |
Zhang Z, Liu Q, Tan J, Zhan X, Liu T, Wang Y, et al. Coating with flexible DNA network enhanced T-cell activation and tumor killing for adoptive cell therapy. Acta Pharm Sin B. 2021;11:1965-1977 pubmed publisher |
Lee E, Szvetecz S, Polli R, Grauel A, Chen J, Judge J, et al. PAX8 lineage-driven T cell engaging antibody for the treatment of high-grade serous ovarian cancer. Sci Rep. 2021;11:14841 pubmed publisher |
Tian X, Cui Z, Wang S, Pan Y, Lata A, Chen X, et al. Low serum IgG4 level: a potential diagnostic biomarker for IgA nephropathy. Ann Transl Med. 2021;9:781 pubmed publisher |
Aschmoneit N, Steinlein S, Kühl L, Seifert O, Kontermann R. A scDb-based trivalent bispecific antibody for T-cell-mediated killing of HER3-expressing cancer cells. Sci Rep. 2021;11:13880 pubmed publisher |
Wang J, Jelcić I, Mühlenbruch L, Haunerdinger V, Toussaint N, Zhao Y, et al. HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis. Cell. 2020;183:1264-1281.e20 pubmed publisher |
Ott M, Tomaszowski K, Marisetty A, Kong L, Wei J, Duna M, et al. Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration. JCI Insight. 2020;5: pubmed publisher |
Riquelme S, Liimatta K, Wong Fok Lung T, Fields B, Ahn D, Chen D, et al. Pseudomonas aeruginosa Utilizes Host-Derived Itaconate to Redirect Its Metabolism to Promote Biofilm Formation. Cell Metab. 2020;31:1091-1106.e6 pubmed publisher |
Sim J, Sockolosky J, Sangalang E, Izquierdo S, Pedersen D, HARRIMAN W, et al. Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα. MAbs. 2019;11:1036-1052 pubmed publisher |
Schoofs T, Barnes C, Suh Toma N, Golijanin J, Schommers P, Gruell H, et al. Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope. Immunity. 2019;50:1513-1529.e9 pubmed publisher |
Collinson Pautz M, Chang W, Lu A, Khalil M, Crisostomo J, Lin P, et al. Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies. Leukemia. 2019;: pubmed publisher |
Zhou Y, Du J, Hou H, Lu Y, Yu J, Mao L, et al. Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy. Front Cell Infect Microbiol. 2017;7:457 pubmed publisher |
Albayati Z, Alyami A, Alomar S, Middleton D, Bonnett L, Aleem S, et al. The Influence of Cytomegalovirus on Expression of HLA-G and its Ligand KIR2DL4 by Human Peripheral Blood Leucocyte Subsets. Scand J Immunol. 2017;86:396-407 pubmed publisher |
Narsale A, Moya R, Robertson H, Davies J. Data on correlations between T cell subset frequencies and length of partial remission in type 1 diabetes. Data Brief. 2016;8:1348-51 pubmed publisher |
